Glutathione

Nutritional peptidesSupplement; IV via clinics

Also known as: GSH (tripeptide)

The body's main antioxidant, made of three amino acids.

Educational reference, not medical advice. Many compounds here are not approved, and products sold as research chemicals are not checked for purity. Plan any use with a licensed clinician.

How it works

Neutralizes free radicals and supports liver detoxification pathways.

Evidence by goal

GoalGradeWhat the grade means
Longevity & energyCLimited human data, case series or practitioner reports
Immune & infectionsCLimited human data, case series or practitioner reports
Blood sugar & metabolicCLimited human data, case series or practitioner reports
Skin, hair & appearanceCLimited human data, case series or practitioner reports

At a glance

Route
Oral (liposomal), IV, or inhaled
Half-life
Minutes in blood

Reported dosing

Oral: 250 to 1000 mg daily. IV: 600 to 2000 mg per session.

Timing: Oral on an empty stomach.

Cycle: Ongoing oral; IV in courses.

From approved labels where they exist, otherwise from published trials and practitioner reports.

Side effects

  • Bloating
  • Asthma flare with inhaled form

Who should avoid it

  • Asthma (inhaled form)
  • FDA has warned against injectable products sold for skin whitening

Often combined with

With NAC, glycine or vitamin C.

Key findings

A 6-month RCT showed daily oral glutathione raised body stores. A small pilot showed liver enzyme improvement in fatty liver.

2026 update

Several countries' regulators have warned about injectable skin-lightening products.

Where it is legal (Oct 2026)

USNo prescription
CanadaNo prescription
MexicoNo prescription
EUNo prescription

Oral is a supplement everywhere; IV is a compounded clinic product in the US.

Sources

Open Glutathione in the Peptide Guide Compare all peptides by goal

Last reviewed November 2026. Regulatory status reflects the US unless noted and changes often.

Natoorales and e4life.io (Mexico residency and immigration help) are sister businesses founded by Ian Kain.

Scroll to Top